Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant DOS in Unresectable Locally Advanced or Lymph Node Metastatic Gastric Cancer
NCT05184803Phase 2Recruiting
- Sponsor
- Asan Medical Center
- Start
- Mar 2022
- Primary completion
- Jun 2027
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of docetaxel, oxaliplatin, tegafur in gastric cancer (GC), sponsored by Asan Medical Center. Started Mar 2022; status: recruiting.
02
Drugs
docetaxeloxaliplatintegafur
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT05184803.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05184803.